Excipient Market Overview: Clariant sets up its first PEG excipients facility in US; India harmonizes 22 excipient monographs

DATA COMPILATION
#PharmaFlow

Pipeline Prospector March 2026 highlights: Lilly to acquire Centessa for US$ 7.8 bn; Merck buys Terns Pharma for US$ 6.7 bn

Stock Recap
#PipelineProspector

Xylocain

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

66 API Suppliers, 20 USDMF, 8 CEP/COS, 5 JDMF, 7 EU WC, 11 KDMF, 22 NDC API, 28 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

127 Drugs in Development

127 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

443 FDF Dossiers, 56 FDA Orange Book, 271 Europe, 21 Canada, 3 Australia, 14 South Africa, 78 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;TOPICAL - 2.5%;2.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, PATCH;TOPICAL - 5%, PATCH;TOPICAL - 70MG;70MG, CREAM;TOPICAL - 7%;7%

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Minakem, 3 Evonik, 3 Rochem International Inc, 12 SPI Pharma, 1 PMC Isochem, 1 Pharm-RX Chemical, 9 Boai NKY Pharmaceuticals Ltd, 3 Gangwal Healthcare, 2 Kewpie Corporation, 23 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 2 Pfanstiehl, 1 Capital Farma, 17 Kirsch Pharma, 1 Cerata Pharmaceuticals LLP, 9 Dr. Paul Lohmann GmbH & Co. KGaA, 4 ACG Worldwide, 17 Actylis, 3 Aeon Procare, 2 Alcedo Pharmachem, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 3 Ashland, 52 BASF, 1 Bioplus Life Sciences, 1 BioSpectra, 5 CD Formulation, 3 Clariant, 13 Corel Pharma Chem, 1 DFE Pharma, 3 Doshion Polyscience, 3 Esteem Industries, 5 Finar, 18 Gangwal Chemicals, 3 Gloria Interchem, 1 Huzhou Sunflower Pharmaceutical, 1 Ideal Cures, 3 Ingredion Pharma Solutions, 1 JJ Chemicals, 5 Kerry, 3 Keval Exports, 1 Kima Chemical, 3 Lonza Capsugel, 8 Lubrizol Life Science Health, 17 Microlex e.U, 4 Nanjing Bold Chemical, 1 Neelkanth MineChem, 3 Nippon Fine Chemical, 1 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 4 Novo Excipients, 2 Pharmatrans-Sanaq, 7 Pluviaendo, 3 Prachin Chemical, 1 Qualicaps, 19 Roquette, 16 Seppic, 2 Shandong Focus Biotechnology Co., Ltd, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 4 Sigachi Industries, 2 Silverline Chemicals, 2 Symrise, 1 The Dow Chemical Company, 2 Ulanqab Kema New Material, 2 Valens Pharmachem, 2 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

82 Topical, 75 Solubilizers, 53 Thickeners and Stabilizers, 50 Fillers, Diluents & Binders, 49 Parenteral, 41 Emulsifying Agents, 31 Disintegrants & Superdisintegrants, 29 Coating Systems & Additives, 29 Direct Compression, 28 Film Formers & Plasticizers, 25 Lubricants & Glidants, 25 Granulation, 24 Surfactant & Foaming Agents, 20 Controlled & Modified Release, 18 Taste Masking, 13 Co-Processed Excipients, 12 Chewable & Orodispersible Aids, 12 API Stability Enhancers, 10 Rheology Modifiers, 8 Empty Capsules, 1 Dry Powder Inhalation, 1 Soft Gelatin

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 120 News #PharmaBuzz

GLOBAL SALES INFORMATION

34 US Medicaid Prescriptions, 45 Regulatory FDF Prices, 4 Annual Reports

MARKET PLACE

31 APIs, 24 FDF Dossiers

PATENTS & EXCLUSIVITIES

12 US Patents, 1 US Exclusivities, 3 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 33 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
31/03/2026	Swati Spentose	India	Daeshin Muyak Co., Ltd.	20201013-210-J-408	Lidocaine	2020-10-13	Swati Spentose Private Limited (Unit-I)	India	Plot No. A-1/2102 & 2103, Phase III, GIDC, VAPI, City: Vapi - 396 195, Dist: Valsad, Gujarat State India
31/03/2026	Delta Synthetic Co. Ltd	Taiwan	Hwail Pharmaceutical Co., Ltd.	20210426-211-J-705(6)	Lidocaine	2022-05-22	Delta Synthetic Co., Ltd.	Taiwan	15, Minsheng St., Tucheng Dist., New Taipei City 23679, Taiwan, ROC

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Xylocain

Xylocain

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

66 API Suppliers

20 USDMF

8 CEP/COS

5 JDMF

7 EU WC

11 KDMF

22 NDC API

28 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

127 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

443 FDF Dossiers

56 FDA Orange Book

271 Europe

21 Canada

3 Australia

14 South Africa

78 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;TOPICAL - 2.5%;2.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

PATCH;TOPICAL - 5%

PATCH;TOPICAL - 70MG;70MG

CREAM;TOPICAL - 7%;7%

RELATED EXCIPIENT COMPANIES

2 EUROAPI

1 Minakem

3 Evonik

3 Rochem International Inc

12 SPI Pharma

1 PMC Isochem

1 Pharm-RX Chemical

9 Boai NKY Pharmaceuticals Ltd

3 Gangwal Healthcare

2 Kewpie Corporation

23 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

2 Pfanstiehl

1 Capital Farma

17 Kirsch Pharma

1 Cerata Pharmaceuticals LLP

9 Dr. Paul Lohmann GmbH & Co. KGaA

4 ACG Worldwide

17 Actylis

3 Aeon Procare

2 Alcedo Pharmachem

6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

3 Ashland

52 BASF

1 Bioplus Life Sciences

1 BioSpectra

5 CD Formulation

3 Clariant

13 Corel Pharma Chem

1 DFE Pharma

3 Doshion Polyscience

3 Esteem Industries

5 Finar

18 Gangwal Chemicals

3 Gloria Interchem

1 Huzhou Sunflower Pharmaceutical

1 Ideal Cures

3 Ingredion Pharma Solutions

1 JJ Chemicals

5 Kerry

3 Keval Exports

1 Kima Chemical

3 Lonza Capsugel

8 Lubrizol Life Science Health

17 Microlex e.U

4 Nanjing Bold Chemical

1 Neelkanth MineChem

CREAM;TOPICAL - 2.5%;2.5% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons